[Media Round-Up]: New Study on Breast Cancer Blood Test

Last week the Clinical Breast Cancer journal published our latest study "A Non-Invasive Blood-Based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years". This study looks at the two prospective clinical trials we conducted to develop a blood-based Combinatorial Proteomic Biomarker Assay (Videssa Breast) to accurately detect breast cancer and reduce false positives from suspicious imaging findings. 

The study concludes: "Videssa^® Breast can effectively detect breast cancer when used in conjunction with imaging and can substantially reduce unnecessary medical procedures, as well as provide assurance to women that they likely do not have breast cancer."

Take a look at what others are saying about the latest study and Videssa Breast here:

	Provista Publishes First Prospective Study on Videssa Breast Test May 23, 2017 | GenomeWeb, 360Dx Adam Bonislawski Read More
	Breast Cancer Liquid Biopsy Study Validates Test as Improved Diagnostic Tool May 24, 2017 | Genetic Engineering & Biotechnology News Read More
	Blood Test May Detect Breast Cancer, Provide Effective Alternative To Invasive Biopsies May 24, 2017 | Medical Daily, Janissa Delzo Read More
	Scientists Just Made a Huge Breakthrough in Diagnosing Breast Cancer May 25, 2017 | Allure Magazine, Rosemary Donahue Read More
	Blood-Based Breast Cancer Detection Test May Help Avoid Biopsy May 25, 2017 | Forbes, John Nosta Read More